← FDA DRUG APPROVALS

FDA ANDA · ANDA070100

FUROSEMIDE

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA070100
TYPE
ANDA
ORIGINAL APPROVAL
1988-01-26
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

FUROSEMIDEDiscontinued
FUROSEMIDE 80MG · TABLET · ORAL

Approval history

1998-12-01Manufacturing (CMC) · Supplement 11AP
1994-12-23Manufacturing (CMC) · Supplement 10AP
1994-10-11Manufacturing (CMC) · Supplement 9AP
1993-08-17Labeling · Supplement 8AP
1992-08-11Labeling · Supplement 7AP
1992-05-01Labeling · Supplement 6AP
1992-04-03Manufacturing (CMC) · Supplement 5AP
1992-04-03Manufacturing (CMC) · Supplement 3AP
1991-04-02Labeling · Supplement 2AP
1988-08-24Manufacturing (CMC) · Supplement 1AP
1988-01-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →